Astrazeneca: Court of Justice upholds first decision finding abuse of dominant position in pharmaceutical sector

P. Van Malleghem, W. Devroe

Research output: Contribution to journalArticleAcademicpeer-review


The court of justice confirms that the supply of misleading information in the context of a request for supplementary protection certificates and the withdrawal of a marketing authorisation within the pharmaceutical sector can constitute abuse of dominant position.
Original languageEnglish
Pages (from-to)228-232
JournalJournal of European Competition Law & Practice
Issue number3
Publication statusPublished - 1 Jan 2013

Cite this